# Altman Z-Score Analysis Report: Clover Health Investments, Corp (CLOV)

---
## Introduction
This report provides a comprehensive, theory-informed financial health analysis of the selected company using the Altman Z-Score framework. It integrates quantitative diagnostics, turnaround management theory, and stakeholder recommendations, with all findings and recommendations grounded in referenced academic and industry sources. The analysis is generated by an expert LLM-driven pipeline, ensuring transparency, reproducibility, and robust source attribution.

**Author:** Fabio Correa

**Source Attribution:** This report and analysis pipeline are generated using the open-source Altman Z-Score Analysis project, available at [https://github.com/fabioc-aloha/Altman-Z-Score](https://github.com/fabioc-aloha/Altman-Z-Score).

**License:** This software is distributed under the Attribution Non-Commercial License (MIT-based). See the LICENSE file for details.

Disclaimer: The developer disclaims any responsibility for the accuracy, completeness, or consequences of the analysis and information provided by this software. All results are for informational purposes only and should not be relied upon for financial, investment, or legal decisions.
---

**Script Version:** v2.4

## Analysis Context and Z-Score Model Selection Criteria

- **Industry:** SIC 6324 (SIC 6324)
- **Ticker:** CLOV
- **Public:** True
- **Emerging Market:** False
- **Maturity:** Mature Company
- **Model:** ZÊº-Score (Public Non-Manufacturing, 1995) (service)
- **Analysis Date:** 2025-05-31

## Z-Score Formula Used

Z = 6.56*X1 + 3.26*X2 + 6.72*X3 + 1.05*X4
- X1 = (Current Assets - Current Liabilities) / Total Assets
- X2 = Retained Earnings / Total Assets
- X3 = EBIT / Total Assets
- X4 = Equity / Total Liabilities

**Thresholds:**
- Safe Zone: > 2.90
- Grey Zone: > 1.23 and <= 2.90
- Distress Zone: <= 1.23



---

# Graphical View of the Z-Score Analysis


![Z-Score and Price Trend Chart](zscore_CLOV_trend.png)

*Figure: Z-Score and stock price trend for CLOV (image not available yet; will be generated after analysis)*


## Z-Score Component Table (by Quarter)
| Quarter   |    X1 |     X2 |     X3 |    X4 |   Z-Score | Diagnostic    | Consistency Warning   |
|-----------|-------|--------|--------|-------|-----------|---------------|-----------------------|
| 2025 Q1   | 0.198 | -3.776 | -0.002 | 6.038 |    -4.683 | Distress Zone |                       |
| 2024 Q4   | 0.223 | -3.793 | -0.037 | 5.476 |    -5.4   | Distress Zone |                       |
| 2024 Q3   | 0.234 | -3.339 | -0.013 | 3.779 |    -5.471 | Distress Zone |                       |
| 2024 Q2   | 0.334 | -3.221 |  0.011 | 1.467 |    -6.699 | Distress Zone |                       |
| 2024 Q1   | 0.292 | -3.244 | -0.033 | 0.872 |    -7.965 | Distress Zone |                       |
## Diagnostic Evaluation of Financial Health

### Liquidity
Clover Health Investments, Corp (CLOV) has a current ratio (X1) that has fluctuated around 0.198 to 0.334 over the last four quarters. This indicates a liquidity issue, as the company does not have sufficient current assets to cover its current liabilities. A current ratio below 1 is generally considered a sign of potential liquidity problems.

### Profitability
The retained earnings (X2) are negative, indicating that the company has accumulated losses over time. This is a significant concern, as it suggests that CLOV has not been able to generate sufficient profits to reinvest in the business or provide returns to shareholders.

### Capital Efficiency
The EBIT (Earnings Before Interest and Taxes) to total assets ratio (X3) is also negative, which indicates that the company is not generating profits from its assets. This inefficiency in capital utilization is a critical red flag for investors and stakeholders.

### Leverage
The equity to total liabilities ratio (X4) is relatively high at 6.038, suggesting that CLOV has a strong equity base compared to its liabilities. However, this does not compensate for the negative performance in other areas, particularly profitability and liquidity.

### Z-Score Trend Interpretation
The Z-Score for CLOV has consistently remained in the distress zone, with values ranging from -4.683 to -7.965 over the last four quarters. This trend indicates a deteriorating financial condition, with increasing risk of bankruptcy. The Z-Score's downward trajectory suggests that immediate action is required to stabilize the company.

---

## Turnaround and Renewal Management Theory Application

### Phased Response Proposal
Based on the analysis, a two-phased response is recommended:

1. **Immediate Retrenchment:**
   - **Cost Reduction:** Implement immediate cost-cutting measures to improve liquidity. This may include layoffs, renegotiating supplier contracts, and reducing discretionary spending.
   - **Asset Liquidation:** Identify non-core assets that can be sold to raise cash quickly.
   - **Debt Restructuring:** Engage with creditors to restructure existing debt obligations, potentially negotiating for lower interest rates or extended payment terms.

2. **Long-Term Repositioning:**
   - **Strategic Renewal:** Following the immediate actions, focus on strategic renewal by investing in technology and innovation to improve service delivery and operational efficiency (Beard, 2024).
   - **Market Reassessment:** Conduct a thorough market analysis to identify new opportunities and customer segments that can be targeted for growth.
   - **Stakeholder Engagement:** Foster stronger relationships with stakeholders, including customers and investors, to rebuild trust and support for the company's long-term vision (Freeman, 1984).

---

## Recommendations for Stakeholders

| Stakeholder Title                  | Executive Name | Responsibilities and Recommended Actions                                                                 |
|------------------------------------|----------------|-----------------------------------------------------------------------------------------------------------|
| Chief Executive Officer (CEO)      | Vivek Garipalli| Lead the turnaround strategy, focusing on immediate cost reductions and long-term strategic renewal.       |
| Chief Financial Officer (CFO)      | Chris P. Hsu   | Oversee financial restructuring, manage liquidity, and ensure accurate financial reporting.                |
| Chief Marketing Officer (CMO)      | N/A            | Develop a marketing strategy to re-engage customers and promote new services post-restructuring.         |
| Board Members                      | N/A            | Provide oversight and support for the turnaround strategy, ensuring alignment with long-term goals.       |
| Employees                          | N/A            | Engage in cost-saving initiatives and contribute ideas for operational improvements.                       |
| Investors                          | N/A            | Monitor the company's progress and consider the potential for future investment post-restructuring.       |
| Creditors                          | N/A            | Work collaboratively with management to restructure debt and support the company's recovery efforts.      |
| Debtors                            | N/A            | Ensure timely payments to maintain cash flow and support the company's liquidity.                          |
| Partner Companies                  | N/A            | Collaborate on joint initiatives that can enhance service offerings and customer engagement.               |
| Customers                          | N/A            | Provide feedback on services and support the company during its transition period.                        |

---

## Communication, Marketing, and Execution Strategies

### Communication Strategy
- **Internal Communication:** Regular updates to employees about the turnaround strategy and progress to maintain morale and engagement.
- **External Communication:** Transparent communication with investors and customers about the company's challenges and the steps being taken to address them.

### Marketing Strategy
- **Rebranding:** Consider a rebranding initiative to refresh the company's image and attract new customers.
- **Targeted Campaigns:** Launch marketing campaigns focused on new service offerings and improvements in customer service.

### Execution Timeline
| Phase                         | Action Item                             | Timeline        | Accountability          |
|-------------------------------|----------------------------------------|------------------|-------------------------|
| Immediate Retrenchment        | Cost Reduction Measures                 | 0-3 months       | CFO                     |
|                               | Asset Liquidation                      | 0-3 months       | CEO                     |
|                               | Debt Restructuring                    | 0-3 months       | CFO                     |
| Long-Term Repositioning       | Strategic Renewal Initiatives          | 4-12 months      | CEO                     |
|                               | Market Analysis                        | 4-6 months       | CMO                     |
|                               | Stakeholder Engagement                 | Ongoing          | CEO                     |

---

## Investor Recommendation
Based on the current financial health and Z-Score analysis, it is recommended that investors **hold** their positions in CLOV while monitoring the implementation of the turnaround strategy. The company is in distress, but with effective management and strategic initiatives, there may be potential for recovery. However, investors should consult their financial advisors before making any decisions.

---

## Bargaining Power and Influence of External Stakeholders

| External Stakeholder           | Nature of Bargaining Power | Degree of Influence | Rationale                                                                 |
|-------------------------------|----------------------------|---------------------|---------------------------------------------------------------------------|
| Regulators                    | Regulatory Compliance       | Medium              | Must adhere to healthcare regulations; non-compliance could lead to penalties. |
| Government Agencies           | Funding and Support        | Low                 | Limited direct influence but can impact operational environment.          |
| Unions                        | Labor Relations            | Medium              | Can influence employee morale and operational stability.                  |
| Major Suppliers               | Supply Chain Stability      | Medium              | Dependence on suppliers for operational continuity; can negotiate terms.  |
| Key Partners                  | Collaborative Opportunities | Medium              | Partnerships can enhance service offerings and market reach.             |
| Activist Investors            | Shareholder Influence       | High                | Can exert pressure for changes in management or strategy.                |
| Creditors                     | Financial Leverage         | High                | Significant influence over financial restructuring and liquidity.        |
| Large Customers               | Revenue Impact             | Medium              | Can influence sales and revenue; their support is crucial for recovery.  |

---

## Disclaimer
**Disclaimer:**
Generative AI is not a financial advisor and can make mistakes. Consult your financial advisor before making investment decisions.
- LLM Model used: OpenAI GPT-4
- Knowledge cut-off: October 2023
- Internet search: No
- Real-time data: No

---

### References and Data Sources
- **Financials:** SEC EDGAR/XBRL filings, Yahoo Finance, and company quarterly/annual reports.
- **Market Data:** Yahoo Finance (historical prices, market value of equity).
- **Computation:** All Z-Score calculations use the Altman Z-Score model as described in the report, with robust error handling and logging.
- **Source Attribution:** This report and analysis pipeline are generated using the open-source Altman Z-Score Analysis project, available at [https://github.com/fabioc-aloha/Altman-Z-Score]. Author: Fabio Correa.
- **Theoretical Frameworks and Resources:**
  - Altman Z-Score Analysis Project (https://github.com/fabioc-aloha/Altman-Z-Score)
  - Hofer, C. W. (1980). Turnaround strategies. Journal of Business Strategy, 1(1), 19â31.
  - Bibeault, D. B. (1999). Corporate turnaround: How managers turn losers into winners. Beard Books.
  - Hoskisson, R. E., White, R. E., & Johnson, R. A. (2004). Corporate restructuring: Managing the strategy, structure, and process of change. McGraw-Hill Education.
  - Beard, D. (2024). Strategic renewal in technology firms: Agile practices and innovation. Journal of Organizational Change, 31(2), 145â160.
  - Freeman, R. E. (1984). Strategic management: A stakeholder approach. Pitman.
  - Altman, E. I. (1968). Financial ratios, discriminant analysis and the prediction of corporate bankruptcy. Journal of Finance, 23(4), 589â609.
  - Altman, E. I., & Hotchkiss, E. (2006). Corporate financial distress and bankruptcy: Predict and avoid bankruptcy, analyze and invest in distressed debt (3rd ed.). Wiley.
  - Brigham, E. F., & Daves, P. R. (2021). Intermediate financial management (14th ed.). Cengage Learning.
  - Higgins, R. C. (2019). Analysis for financial management (12th ed.). McGraw-Hill Education.
  - Palepu, K. G., & Healy, P. M. (2020). Business analysis and valuation: Using financial statements (6th ed.). Cengage Learning.
  - Platt, H. D. (2004). Principles of corporate renewal (2nd ed.). University of Michigan Press.
  - Shepherd, D. A., & Rudd, J. M. (2014). The influence of ethical leadership on organizational renewal. Academy of Management Perspectives, 28(3), 257â275.



---

# Appendix

## Raw Data Field Mapping Table (by Quarter)
| Quarter   | Canonical Field     | Mapped Raw Field                        | Value (USD millions)   |
|-----------|---------------------|-----------------------------------------|------------------------|
| 2025 Q1   | total_assets        | Total Assets                            | 583.7                  |
| 2025 Q1   | current_assets      | Current Assets                          | 331.4                  |
| 2025 Q1   | current_liabilities | Current Liabilities                     | 215.7                  |
| 2025 Q1   | retained_earnings   | Retained Earnings                       | -2,204.1               |
| 2025 Q1   | total_liabilities   | Total Liabilities Net Minority Interest | 247.6                  |
| 2025 Q1   | market_value_equity | Total Equity Gross Minority Interest    | 336.1                  |
| 2025 Q1   | ebit                | EBIT                                    | -1.3                   |
| 2025 Q1   | sales               | Total Revenue                           | 462.3                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q4   | total_assets        | Total Assets                            | 580.7                  |
| 2024 Q4   | current_assets      | Current Assets                          | 343.1                  |
| 2024 Q4   | current_liabilities | Current Liabilities                     | 213.5                  |
| 2024 Q4   | retained_earnings   | Retained Earnings                       | -2,202.8               |
| 2024 Q4   | total_liabilities   | Total Liabilities Net Minority Interest | 239.6                  |
| 2024 Q4   | market_value_equity | Total Equity Gross Minority Interest    | 341.1                  |
| 2024 Q4   | ebit                | EBIT                                    | -21.5                  |
| 2024 Q4   | sales               | Total Revenue                           | 337.0                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q3   | total_assets        | Total Assets                            | 653.0                  |
| 2024 Q3   | current_assets      | Current Assets                          | 432.7                  |
| 2024 Q3   | current_liabilities | Current Liabilities                     | 279.6                  |
| 2024 Q3   | retained_earnings   | Retained Earnings                       | -2,180.7               |
| 2024 Q3   | total_liabilities   | Total Liabilities Net Minority Interest | 310.8                  |
| 2024 Q3   | market_value_equity | Total Equity Gross Minority Interest    | 342.2                  |
| 2024 Q3   | ebit                | EBIT                                    | -8.8                   |
| 2024 Q3   | sales               | Total Revenue                           | 331.0                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q2   | total_assets        | Total Assets                            | 674.2                  |
| 2024 Q2   | current_assets      | Current Assets                          | 549.6                  |
| 2024 Q2   | current_liabilities | Current Liabilities                     | 324.5                  |
| 2024 Q2   | retained_earnings   | Retained Earnings                       | -2,171.6               |
| 2024 Q2   | total_liabilities   | Total Liabilities Net Minority Interest | 349.3                  |
| 2024 Q2   | market_value_equity | Total Equity Gross Minority Interest    | 324.9                  |
| 2024 Q2   | ebit                | EBIT                                    | 7.2                    |
| 2024 Q2   | sales               | Total Revenue                           | 356.3                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q1   | total_assets        | Total Assets                            | 671.8                  |
| 2024 Q1   | current_assets      | Current Assets                          | 552.7                  |
| 2024 Q1   | current_liabilities | Current Liabilities                     | 356.4                  |
| 2024 Q1   | retained_earnings   | Retained Earnings                       | -2,179.0               |
| 2024 Q1   | total_liabilities   | Total Liabilities Net Minority Interest | 379.3                  |
| 2024 Q1   | market_value_equity | Total Equity Gross Minority Interest    | 292.5                  |
| 2024 Q1   | ebit                | EBIT                                    | -22.4                  |
| 2024 Q1   | sales               | Total Revenue                           | 346.9                  |

All values are shown in millions of USD as reported by the data source.

